File:NLC416-08jh016112-94463 新藥淺說.pdf

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search
Go to page
next page →
next page →
next page →

Original file(789 × 1,070 pixels, file size: 3.09 MB, MIME type: application/pdf, 117 pages)

Captions

Captions

Add a one-line explanation of what this file represents

Summary

[edit]
新藥淺說   (Wikidata search (Cirrus search) Wikidata query (SPARQL)  Create new Wikidata item based on this file)
Author
吳蔚編
image of artwork listed in title parameter on this page
Title
新藥淺說
Publisher
中華書局[發行者]
Description

目錄
第一章 藥和人生的關係
第二章 麻醉藥和安眠藥
第一節 麻醉藥應用的歷史
第二節 全身麻醉藥
ⅰ 醚
ⅱ 氯仿
ⅲ 氯乙烷
ⅳ 環丙烷
ⅴ 乙烯
第三節 局部麻醉藥
ⅰ 古柯鹼
ⅱ 斯多佛因
ⅲ 普魯鹼
ⅳ 其他局部麻醉藥
第四節 安眠藥
ⅰ 溴異戊醘脲
ⅱ 巴比土酸屬安眠藥
a 凡樂那
b 寐底拿
c 阿米太
d 羅米那
第三章 退熱和鎮痛藥
第一節 退熱冰
第二節 非內西丁
第三節 愛爾邦
第四節 茂來丁
第五節 辟拉密同
第六節 阿斯匹靈
第四章 胃腸病藥
第一節 制酸劑
第二節 通便藥
ⅰ 增加體積的通便藥
ⅱ 刺激性通便藥
第五章 化學治療劑ⅰ(金屬有機化合物)
第一節 有機砷化合物
ⅰ 阿斯非納明
ⅱ 新阿斯非納明
ⅲ 米奧消梅散
ⅳ 馬法生
ⅴ 二氯馬法生
ⅵ 斯篤伐索兒
ⅶ 卡排松
第二節 有機銻化合物
ⅰ 吐酒石
ⅱ 福鳥定
ⅲ 新斯銻苯散
第六章 化學治療劑ⅱ(磺酰胺類藥物)
第一節 磺酰胺類發現的歷史
第二節 磺胺吡啶
第三節 磺胺噻唑
第四節 磺胺噠嗪
第五節 阿爾巴息特
第六節 磺酰胍
第七節 益解粉
第八節 丁二酰磺胺噻唑
第九節 大愛茸與普樂明
第十節 音樂滅查
第十一節 磺酰胺類藥物的治療作用
第七章 化學治療劑ⅲ(抗生素類)
第一節 什麼叫做抗生素
第二節 抗生素類發現的歷史
第三節 青黴素
ⅰ 青黴素的化學
ⅱ 青黴素的製造
一 表面培養法
二 沉沒培養法
三 麥麩培養法
ⅲ 青黴素的適應症
ⅳ 青黴素的製劑和用量
第四節 鏈黴素
ⅰ 鏈黴素的化學
ⅱ 鏈黴素的製造
ⅲ 鏈黴素的適量症
ⅳ 鏈黴素的製劑與劑量
第五節 泰羅斯新
第八章 化學治療劑ⅳ(瘧疾治療劑)
第一節 奎寧
第二節 撲虐母星
第三節 安的平
第四節 最新的瘧疾治療藥
第九章 維他命和激素
第一節 激素的定義
第二節 研究激素的歷史
第三節 甲狀腺素
ⅰ 研究甲狀腺素的歷史
ⅱ 甲狀腺素的化學
ⅲ 甲狀腺素的製造
ⅳ 因甲狀腺分泌失常所引起的疾患
ⅴ 治療方法
第四節 福腎素
ⅰ 研究副腎素的歷史
ⅱ 副腎素的化學
ⅲ 副腎素的製造
ⅳ 副腎素的生理作用及應用
第五節 胰島素
ⅰ 研究胰島素的歷史
ⅱ 胰島素的化學
ⅲ 胰島素的製造
ⅳ 胰島素的生理作用及應用
第六節 男性激素
ⅰ 男性激素的化學
ⅱ 男性激素的生理作用及應用
第七節 女性激素
ⅰ 研究女性激素的歷史
ⅱ 女性激素的化學
ⅲ 女性激素的生理作用
ⅳ 女性激素分泌失常所引起的疾病及其治療
第十章 衛生用新藥
第一節 ddt
第二節 安妥
第三節 666
第四節 其他衛生用新藥
第十一章 藥物的調製
第一節 藥片的製造
第二節 注射液的製造

Language Chinese
Publication date 民國37[1948]
Source
institution QS:P195,Q732353
(民國時期文獻 民國圖書)
主題
InfoField
新藥
中圖分類
InfoField
R97-49
載體形態
InfoField
108頁

Licensing

[edit]
This image is in the public domain because it is a mere mechanical scan or photocopy of a public domain original, or – from the available evidence – is so similar to such a scan or photocopy that no copyright protection can be expected to arise. The original itself is in the public domain for the following reason:
Public domain
This image is now in the public domain in China because its term of copyright has expired.

According to copyright laws of the People's Republic of China (with legal jurisdiction in the mainland only, excluding Hong Kong and Macao), amended November 11, 2020, Works of legal persons or organizations without legal personality, or service works, or audiovisual works, enter the public domain 50 years after they were first published, or if unpublished 50 years from creation. For photography works of natural persons whose copyright protection period expires before June 1, 2021 belong to the public domain. All other works of natural persons enter the public domain 50 years after the death of the creator.
According to copyright laws of Republic of China (currently with jurisdiction in Taiwan, Penghu, Kinmen, Matsu, etc.), all photographs and cinematographic works, and all works whose copyright holder is a juristic person, enter the public domain 50 years after they were first published, or if unpublished 50 years from creation, and all other applicable works enter the public domain 50 years after the death of the creator.

Important note: Works of foreign (non-U.S.) origin must be out of copyright or freely licensed in both their home country and the United States in order to be accepted on Commons. Works of Chinese origin that have entered the public domain in the U.S. due to certain circumstances (such as publication in noncompliance with U.S. copyright formalities) may have had their U.S. copyright restored under the Uruguay Round Agreements Act (URAA) if the work was under copyright in its country of origin on the date that the URAA took effect in that country. (For the People's Republic of China, the URAA took effect on January 1, 1996. For the Republic of China (ROC), the URAA took effect on January 1, 2002.[1])
To uploader: Please provide where the image was first published and who created it or held its copyright.

You must also include a United States public domain tag to indicate why this work is in the public domain in the United States. Note that this work might not be in the public domain in countries that do not apply the rule of the shorter term and have copyright terms longer than life of the author plus 50 years. In particular, Mexico is 100 years, Jamaica is 95 years, Colombia is 80 years, Guatemala and Samoa are 75 years, Switzerland and the United States are 70 years, and Venezuela is 60 years.


čeština  Deutsch  English  português  română  slovenščina  Tagalog  Tiếng Việt  македонски  русский  മലയാളം  ไทย  한국어  日本語  简体中文‎  繁體中文  +/−



This tag is designed for use where there may be a need to assert that any enhancements (eg brightness, contrast, colour-matching, sharpening) are in themselves insufficiently creative to generate a new copyright. It can be used where it is unknown whether any enhancements have been made, as well as when the enhancements are clear but insufficient. For known raw unenhanced scans you can use an appropriate {{PD-old}} tag instead. For usage, see Commons:When to use the PD-scan tag.


Note: This tag applies to scans and photocopies only. For photographs of public domain originals taken from afar, {{PD-Art}} may be applicable. See Commons:When to use the PD-Art tag.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current20:34, 10 June 2023Thumbnail for version as of 20:34, 10 June 2023789 × 1,070, 117 pages (3.09 MB)PencakeBot (talk | contribs)Upload 新藥淺說 (1/1) by 吳蔚編 (batch task; nlc:data_416,08jh016112,94463; 民國圖書.4; 新藥淺說)

The following page uses this file:

Metadata